Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

OBJECTIVES: Muckle-Wells syndrome (MWS) is an autoinflammatory disease characterized by excessive interleukin-1 (IL-1) release, resulting in recurrent fevers, sensorineural hearing loss, and amyloidosis. IL-1 inhibition with anakinra, an IL-1 receptor antagonist, improves clinical symptoms and infla...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kuemmerle-Deschner, Jasmin B, Wittkowski, Helmut, Tyrrell, Pascal N, Koetter, Ina, Lohse, Peter, Ummenhofer, Katharina, Reess, Fabian, Hansmann, Sandra, Koitschev, Assen, Deuter, Christoph, Bialkowski, Anja, Foell, Dirk, Benseler, Susanne M
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2013
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4060562/
https://ncbi.nlm.nih.gov/pubmed/23718630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4237
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires